Cadila Pharmaceuticals Issues Class 4 Defect Notification for Mirtazapine 30mg Tablets
Cadila Pharmaceuticals Limited reported a defect in the EAN barcode on Mirtazapine 30mg tablets, affecting distribution.
Asset / Drug
Drug and asset intelligence for Cadila with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.